Expressed Alu repeats as a novel, reliable tool for normalization of real-time quantitative RT-qPCR data

Genome Biology

Volumn 11, Issue 1, 2010, Pages

  Marullo, Manuela ^a   Zuccato, Chiara ^a   Mariotti, Caterina ^b   Lahiri, Nayana ^c   Tabrizi, Sarah J ^c   Di Donato, Stefano ^b   Cattaneo, Elena ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BRAIN DERIVED NEUROTROPHIC FACTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 8; MESSENGER RNA; TRANSCRIPTOME; TROPONIN C; TROPONIN C TYPE 1; UNCLASSIFIED DRUG; PRIMER DNA; RNA;

ALGORITHM; ALU SEQUENCE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE MARKER; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; INTERSPERSED REPEAT; MUSCLE BIOPSY; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; VASTUS LATERALIS MUSCLE; ADULT; BIOLOGICAL MODEL; FEMALE; GENETICS; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; STANDARD;

ADULT; ALU ELEMENTS; BETA 2-MICROGLOBULIN; DNA PRIMERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MODELS, GENETIC; MUSCLE, SKELETAL; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER;

EID: 77649302072     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2010-11-1-r9     Document Type: Article

References (18)

1. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol, 2002, 3:1-12
2. Yulug IG, Yulug A, Fisher EM: The frequency and position of Alu repeats in cDNAs, as determined by database searching. Genomics 1995, 27(3):544-8
3. Zuccato C, Cattaneo E: Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 2009, 5:311-22.
4. Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J, Sun B, Tandon NN: Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 2002, 87:728-34
5. Radka SF, Holst PA, Fritsche M, Altar CA: Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res 1996, 709:122-30.
6. Trajkovska V, Marcussen AB, Vinberg M, Hartvig P, Aznar S, Knudsen GM: Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data. Brain Res Bull. 2007, 73(1-3):143-9.
7. Batzer MA, Deininger PL: Alu repeats and human genomic diversity. Nat Rev Genet. 2002 3(5):370-9.
8. Zuccato C, Marullo M, Conforti P, MacDonald ME, Tartari M, Cattaneo E: Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease. Brain Pathol 2008,18:225-38.
9. Strand AD, Aragaki AK, Shaw D, Bird T, Holton J, Turner C, Tapscott SJ, Tabrizi SJ, Schapira AH, Kooperberg C, Olson JM: Gene expression in Huntington's disease skeletal muscle: a potential biomarker. Hum Mol Genet. 2005, 14(13):1863-76. Epub 2005 May 11.
10. Suzuki: Suzuki T, Higgins PJ, Crawford DR. Control selection for RNA quantitation. Biotechniques 2000,29:332-337.
11. Bustin SA: Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000,25:169-93. Review.
12. Bustin SA: Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 2002,29:23-39. Review.
13. Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R, Mathieu C : The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 2003, 14:33-43.
14. Pachot A, Blond JL, Mougin B, Miossec P: Peptidylpropyl isomerase B (PPIB): a suitable reference gene for mRNA quantification in peripheral whole blood. J Biotechnol 2004, 114:121-4.
15. Cha JH: Transcriptional signatures in Huntington's disease. Prog Neurobiol 2007, 83:228-48. Review.
16. Zuccato C, Cattaneo E: Role of brain-derived neurotrophic factor in Huntington's disease. Prog Neurobiol 2007, 81:294-330. Review.
17. Conforti P, Ramos C, Apostol BL, Simmons DA, Nguyen HP, Riess O, Thompson LM, Zuccato C, Cattaneo E: Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347. Mol Cell Neurosci 2008, 39:1-7.
18. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT: The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009, 55(4):611-22.